key: cord-0871159-o9qmdhk5 authors: Ma, Ling; Xie, Wen; Li, Danyang; Shi, Lei; Ye, Guangming; Mao, Yanhong; Xiong, Yao; Sun, Hui; Zheng, Fang; Chen, Zhimin; Qin, Jyuling; Lyu, Jing; Zhang, Yuanzhen; Zhang, Ming title: Evaluation of sex‐related hormones and semen characteristics in reproductive‐aged male COVID‐19 patients date: 2020-07-04 journal: J Med Virol DOI: 10.1002/jmv.26259 sha: f0a5d64fc93d058b258934f67d5c2eb94d53e1bc doc_id: 871159 cord_uid: o9qmdhk5 In the past several months, the outbreak of SARS‐CoV‐2‐associated infection (coronavirus disease 2019, COVID‐19) developed rapidly and has turned into a global pandemic. Although SARS‐CoV‐2 mainly attacks respiratory systems, manifestations of multiple organs have been observed. Great concern was raised about whether COVID‐19 may affect male reproductive functions. In this study, we collected semen specimens from twelve male COVID‐19 patients for virus detection and semen characteristics analysis. No SARS‐CoV‐2 was found in semen specimens. 8 out of 12 patients had normal semen quality. We also compared the sex‐related hormone levels between 119 reproductive‐aged men with SARS‐CoV‐2 infection and 273 age‐matched control men. A higher serum luteinizing hormone (LH) and a lower ratio of testosterone (T) to LH were observed in the COVID‐19 group. Multiple regression analysis indicated that serum T:LH ratio was negatively associated with white blood cell counts (WBC) and c‐reactive protein (CRP) level in COVID‐19 patients. It's the first report about semen assessment and sex‐hormone evaluation in reproductive‐aged male COVID‐19 patients. Although further study is needed to clarify the reasons and underlying mechanisms, our study presents an abnormal sex hormone secretion among COVID‐19 patients, suggesting that attention should be paid to reproductive function evaluation in the follow‐up. This article is protected by copyright. All rights reserved. Since the first report in December 2019, a novel coronavirus-associated infection (called coronavirus disease 2019, COVID-19) spread rapidly and triggered a global pandemic. As of June 15, 2020, a total of 200 countries or regions were affected and more than 7,970,000 cases have been reported in the whole world. COVID-19 is caused by beta-coronavirus which is currently named SARS-CoV-2 due to its high sequence similarity (~80%) with SARS-CoV [1] . The common symptoms of COVID-19 include fever, dry cough, fatigue and dyspnea, but manifestations of multiple organs or systems have been reported, such as cardiovascular, urinary, gastrointestinal and liver injury [2] [3] [4] . It was suggested that SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) and the cellular serine protease (TMPRSS2) for entry into host cells [5] . Based on scRNA-seq profiling of human testes, Wang ZP et al. reported that ACE2 is predominantly enriched in spermatogonia, Leydig and Sertoli cells [6] . In a retrospective study involving 1099 cases, it's shown that the percentage of male COVID-19 patients was nearly 60% and around 55% of them were reproductive-aged (15~49 years old) [7] . Therefore, concern was raised about whether SARS-CoV-2 may affect male reproductive system. There are controversial opinions on whether SARS-CoV-2 can be present in semen. A recent study indicated that SARS-CoV-2 was detectable in semen specimens of male COVID-19 patients (6 out of 38, 15.8%), including the recovering patients (2 out of 23, 8.7%) [8] . But the other two teams reported the absence of SARS-CoV-2 in semen from male COVID-19 patients in the recovery stage [9] [10] . Besides, it should be noted that virus-associated febrile illness may exert negative influence on male reproductive function via This article is protected by copyright. All rights reserved. Accepted Article multiple mechanisms. Apart from the direct invasion and damage by virus, many other factors such as fever, inflammation, hypoxia or drugs may also affect male hypothalamic-pituitary-gonadal (HPG) axis and spermatogenesis. Based on autopsy of six patients who died of SARS, Xu et al. presented the evidence of orchitis although no SARS virus was found in testes [11] . Therefore, in order to better understand the impact of COVID-19 on fertility, testicular endocrine function and spermatogenesis should also be assessed. In this study, we compared the sex-related hormones between 119 reproductive-aged male COVID-19 patients and 273 age-matched uninfected men. Moreover, semen samples from twelve patients were collected for SARS-CoV-2 virus detection and semen characteristics analysis. Our study provides valuable clinical evidences which will facilitate further evaluation of the effect of COVID-19 on male reproductive function. This study was reviewed and approved by the Medical Ethical Committee of Zhongnan Hospital of Wuhan University (approval number 2020033-1). We recruited 119 reproductive-aged (median age 39 years, range 20-49) male patients for sex-related hormones analysis, who were admitted to Wuhan Leishenshan Hospital from March 5 to March 31, 2020. A convenient sampling strategy was employed, in which all consecutive patients meeting inclusion criteria were recruited. The blood samples were collected for the routine medical purposes. After the required laboratory tests were completed, the residual serum was collected for male hormone profiles detection. Since the residual serum samples were usually discarded as a medical waste otherwise, This article is protected by copyright. All rights reserved. and the procedure exerted no additional burden nor harm on the patients, written informed consent was waived in this part of the study. The patients were in stable clinical status when the study was conducted and all of them had been discharged from the hospital as of April 15. The control group came from the men who received sex hormone measurement as a part of fertility evaluation before marriage or when their partners were planning to get pregnant. 273 agematched men (median age 39 years, range 24-49) were randomly selected and the data of their sex-related hormones were obtained. This article is protected by copyright. All rights reserved. Clinical information, laboratory findings, radiological features and outcome data of COVID-19 patients were obtained from medical records. In the control group, the data of serum testosterone (T), estradiol (E2), follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels were obtained from the database kept in our reproductive medical center. All the men in the control group received hormone detection in the morning. The researcher in charge of data collection was blinded to their fertility status in order to minimize the selection bias. All information was obtained and curated with a standardized data collection form, which was double checked by two researchers independently. Considering the diurnal pattern of sex-related hormones, in the COVID-19 group, only blood samples collected at the same time of the day as the control group were selected. Residual serum was collected and kept at -20°C. Serum T, E2, FSH and LH were detected by electrochemiluminescent immunoassays according to the protocol from the manufacturer (cobas e411, Roche, Switzerland). The ratios of T to LH, T to E2 and FSH to LH were calculated. Semen samples were obtained by masturbation after an abstinence period of 2~7 days (with a median of 4 days) and processed within 1h of ejaculation for analysis. Semen assessment was performed according to WHO laboratory manual for the examination and processing of human semen (5th Edition). The characteristics such as total sperm count, sperm motility, vitality, and morphology were detected. Low motility is defined as progressive sperm (PR) <32% or PR + non-progressive (NR) <40%. Sperm DNA fragmentation was assessed by sperm chromatin dispersion (SCD) test (sperm DNA fragmentation assay kit, Wright-Giemsa stain method, Ankebio, This article is protected by copyright. All rights reserved. Anhui, China) as described previously with minor modifications [13] . A minimum of 500 spermatozoa per sample were scored under the ×100 objective of the microscope. DNA fragmentation index (DFI, %) equals to the percentage of sperm cells with fragmented DNA in the total sperm cells. A semen aliquot was centrifuged at 600g to isolate seminal plasma from whole semen cells. SARS-CoV-2 virus in both seminal plasma and spermatozoa was detected by qRT-PCR. The primers and the cycling parameters were as reported previously [14] . qRT-PCR of SARS-CoV-2 was performed using Chinese Center for Disease Control and Prevention (CDC) recommended Kit (BioGerm, shanghai, China). Serum antibodies (IgM and IgG) were detection by a commercial colloidal gold test kit (Wondfo biotechnology, Guangzhou, China). Sample collection, processing, and laboratory testing complied with WHO guidance. All statistical analysis was performed using Graphpad Prism 6.04 (San Diego, USA) and SPSS 16.0 (Chicago, IL, USA). Continuous variables were expressed as means ± standard deviations (SD) or medians and interquartile ranges (IQR) as appropriate. Categorical variables were summarized as the counts and percentages (%). The distribution of data was analyzed by Kologorov-Smirov test. Differences between two groups were analyzed by Student's t test (parametric) or Mann-Whitney U test (non-parametric). Multiple linear regression was performed to analyze the relationship between serum T:LH ratio and the clinical characteristics of the COVID-19 patients. Statistical significance was defined as p value of < 0.05. This article is protected by copyright. All rights reserved. 7.6 ± 2.2 in the other 8 patients), among whom two participants also had poor sperm morphology (defined as normal morphology <4%). Three cases (case 8, 9, 11) reported loss of libido after COVID-19 attack. Case 8 also complained for loss of morning erection. Case 8 and 9 had normal semen quality. The details can be seen in Table 1 . Three patients (case 3, 4, 11) received semen assessment(s) in our center before SARS-CoV-2 infection (Seen in Table 2 ). Case 11 showed a decrease in sperm motility (31.1%, PR+NP) after COVID-19. However, since there is a biological variation in semen parameters over time, repeated detections in the follow-up may be needed to interpret this change. Case 4 was diagnosed as asthenospermia before COVID-19, and no much alteration was seen in his current semen characteristics. Semen parameters of case 3 This article is protected by copyright. All rights reserved. were defined as normal before and after COVID-19, but a decrease in total mobile sperm number was observed. Among 119 male COVID-19 patients whose sex-hormones were detected, 2.52 % (3/119) were diagnosed as "mild type", 84.03% (100/119) as "moderate type", 11.76% (14/119) as "severe type" and 1.68 % (2/119) as Table 3 . Compared to the control group, COVID-19 patients had significantly higher serum LH (p<0.0001). Although there was no statistical difference in serum T (p=0.1886) or FSH (p=0.5585) between the two groups, the ratios of T:LH (p<0.0001) and FSH: LH (p<0.0001) were decreased in the COVID-19 group (seen in Table 4 ). In the control group, only 150 out of 273 men had the data of serum E2. Since they were also age-matched with the COVID-19 patients (p=0.3295), the comparison of E2 or T: E2 ratio was performed between them and the COVID-19 group. No significant difference was observed in either E2 (p=0.9364) or T: E2 ratio (p=0.7096). (seen in Supplemental Table 2) By multivariable linear regression analysis, it can be seen that serum T:LH ratio in the COVID-19 group was negatively associated with white blood cell counts (p=0.0069) and CRP level (p=0.0285). (Seen in Table 5 ) This article is protected by copyright. All rights reserved. The main functions of testes are spermatogenesis and steroidogenesis. It is known that a broad range of virus families, including human immunodeficiency virus (HIV), mumps virus, influenza, Zika virus, etc., may attack testes and affect male reproductive function [15] . Except for the direct damage of testes by virus, many other factors such as fever, inflammation, and dysregulation of HPG axis may also impair testosterone secretion or sperm production [15, 16] . Therefore, in order to better understand the effect of COVID-19 on male reproductive system, not only the possibility of sex transmission, but also the status of reproductive endocrine and spermatogenesis should be evaluated. Using qRT-PCR, we didn't find SARS-CoV-2 virus in semen samples from twelve male COVID-19 patients. This finding is consistent to two recent reports [9, 10] . The protection by blood-testes barrier and the low incidence of viremia in COVID-19 are both possible reasons [17] . Besides, since most of the semen specimens in this study were obtained from patients in the recovery stage, the virus (if ever existed in semen) may be cleared up by the time of detection. We further compared the sex hormone profiles between 119 COVID-19 patients and 273 age-matched control men. Although serum T levels did not statistically change in the COVID-19 group, a higher serum LH level and a lower serum T: LH ratio were observed in comparison to the control group. The basal T level in the population varies widely, thus the ratio between hormones, such as T:LH ratio was considered as a better parameter for male gonad function evaluation [18] . Abundant IgG precipitation and leukocyte infiltration has been observed in testes from patients who died of SARS [11] . This article is protected by copyright. All rights reserved. Therefore, authors propose that immunological injury may also play a role in COVID-19. Virus-induced inflammation triggered systematic or local release of cytokines, such as interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), interferon (IFN) and monocyte chemoattractant protein 1(MCP-1), etc [19] . Those cytokines may do harm to testicular cells. For example, IL-6 has been implicated to impair Leydig cell differentiation [20] . And despite the anti-viral function, IFN-γ has been shown to inhibit testosterone production by suppressing the expression of rate-limiting enzyme steroidogenic acute regulatory protein (StAR) [21] . Impaired T secretion induces LH release which can maintain T level temporarily. By multiple linear regression analysis, we demonstrated that T:LH ratio was negatively associated with WBC count and CPR level of COVID-19 patients. As an acute-phase protein, elevated CRP is accompanied with cytokines release and can reflects the severity of inflammation [22] . Therefore, further study about the effect of immunological disturbance in COVID-19 on testicular cells is suggested. Besides, manifestations of central nevous system in COVID-19 patients have been reported, including increased antidiuretic hormone secretion by hypothalamus [23] . Emotional, physical, or psychological stresses and pain associated with infections can stimulate the hypothalamohypophyseal axis. Hence the disturbance of hypothalamic-pituitary and resulted abnormality in LH secretion rhythm may also be a reason. Moreover, the role of sexhormone binding globin (SHBG) should also be considered. By binding to SHBG, the active free testosterone decreases and LH secretion may be induced. Although it remains unclear whether and how SHBG production is affected by COVID-19, elevated SHBG level has been reported in many pathological conditions, such as fatty liver, hepatitis, or stress after anaesthesia and surgery [24] . Finally, it should be pointed out that basal LH This article is protected by copyright. All rights reserved. level in the patient group before COVID-19 attack also matters. Though only 4 of 119 patients in this study reported coexisting chronic diseases, the influence of unreported pre-existing illness on male gonad function cannot be completely excluded due to the retrospective nature of the study. Unlike LH, FSH is mainly suppressed by inhibin B secreted by Sertoli cells and reflects the function of Sertoli cells to a certain extent. Estradiol in man normally comes from peripheral aromatization of androgens. In this study, no significant difference was present in serum FSH, serum E2 and the ratio of T: E2 between the two groups. Thus, the altered LH secretion might not be caused by a single reason but the combination of several factors. Semen parameters were described in twelve patients. 8 participants had normal semen characteristics after COVID-19. Increased sperm DNA fraction percentage was only seen in 4 patients with poor semen quality. Among three men receiving semen analysis before COVID-19 attack, the total mobile sperm count in two cases showed a slight decrease in comparison to their previous records. However, due to the limited sample size and the large biological variation in semen parameters, further well-designed prospective cohort study is needed to clarify the effect of COVID-19 on spermatogenesis. There are some limitations in this study. First, all the semen samples came from non-severe patients and most of them were in the recovery stage. Whether SARS-CoV-2 can invade testis in severe patients or during incubation period is still unknown. Second, the sample size for semen assessment is limited. A prospective cohort involving more cases is required. Third, people with chronic disease are more vulnerable to COVID-19 attack. Since we don't know the sex hormone baseline in the patient group before This article is protected by copyright. All rights reserved. infection, it should be quite cautious to interpret the influence of COVID-19 on male endocrine function. Our study also has some strengths. First, it's the first study describing the semen characteristics of male COVID-19 patients. Second, it adds more evidence that SARS-CoV-2 was undetectable in semen and there was no risk of sex transmission after a certain interval since symptom onset (at a median time of 78.5 days in this study). Finally, it describes the phenomenon of increased LH secretion in COVID-19 patients. Further studies should be performed to determine whether it is a transient dysregulation or has prolonged effects, and whether it is a pre-existing condition or a result of COVID-19 attack. The underlying mechanisms should also be explored. Gonadal function evaluation including semen examination is necessary in the follow-up of the men who recovered from COVID-19. And appropriate interval time should be determined for those who has a plan of procreation. Table 1. Semen characteristics of twelve reproductive-aged men after COVID-19 Return of the Coronavirus: 2019-nCoV Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor This article is protected by copyright. All rights reserved. Accepted Article ACE2 and the cellular protease TMPRSS2 for entry into target cells scRNA-seq Profiling of Human Testes Reveals the Presence of ACE2 Receptor, a Target for SARS-CoV-2 Infection Clinical Characteristics of Coronavirus Disease 2019 in China Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease No evidence of SARS-CoV-2 in semen of males recovering from COVID-19 Absence of 2019 novel coronavirus in semen and testis of COVID-19 patients Orchitis: a complication of severe acute respiratory syndrome (SARS National Health Commission of the People's Republic of China Simple determination of human sperm DNA fragmentation with an improved sperm chromatin dispersion test Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan Viral threat to male fertility History of febrile illness and variation in semen quality Detection of SARS-CoV-2 in Different Types of Clinical Specimens Histological and hormonal testicular function in oligo/azoospermic infertile men Cytokine release syndrome in severe COVID-19 Interleukin 6 inhibits the differentiation of rat stem Leydig cells Interferon-γ inhibits the steroidogenic acute regulatory protein messenger ribonucleic acid expression and protein levels in primary cultures of rat Leydig cells Inflammaging decreases adaptive and innate immune responses in mice and humans COVID-19-associated SIADH: a clue in the times of pandemic Genderspecific differences in sex hormones and cytokines in patients undergoing major abdominal surgery This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.